Share This

Related Topics News -

     
 Title only   |   Print 
     
京東健康與廣藥深化合作

2024-05-30T  
《業績》白雲山首季純利19.58億元人民幣升2.6%

2024-04-26T  
白雲山分公司藥物通過國家藥監局仿製藥一致性評價

2024-04-22T  
白雲山新研發非化學原理藥獲國家藥監局批准上市

2024-04-18T  
《公司業績》白雲山全年純利40.56億人民幣增2.3% 派息74.9分

2024-03-17T  
廣藥集團董事長:倡大力推動生物醫藥數字經濟發展

2024-03-04T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.